Operative failure in the era of focused parathyroidectomy: a contemporary series of 845 patients.

Focused parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IPM) may lead to higher failure rates because of missed multiglandular disease.
Retrospective review of prospectively collected data.
Tertiary referral center.
From September 8, 1993, through January 30, 2009, a total of 845 consecutive patients with sporadic primary hyperparathyroidism underwent focused parathyroidectomy guided by IPM at a single institution.
Parathyroid hormone dynamics and perioperative data were analyzed for factors affecting outcome. Operative failure was defined as hypercalcemia with elevated parathyroid hormone levels within 6 months after parathyroidectomy. Detailed intraoperative data from the failed operations were also reviewed.
Of 723 patients followed up for at least 6 months, 702 (97.1%) had successful parathyroidectomy, and 21 (2.9%) had failed parathyroidectomy. The major cause of operative failure was the surgeon's inability to find the abnormal parathyroid gland (16 of 21 patients [76.2%]). In the remaining patients, IPM results were false-positive in 5 of 21 patients (23.8%) or 0.7% overall. Among the cohort, IPM correctly identified missed multiglandular disease in 33 of 38 patients (86.8%). Patients having operative failure were more likely to have a history of thyroidectomy or parathyroidectomy and were less likely to have correct findings on technetium Tc 99m sestamibi or ultrasonographic localizing studies compared with patients having operative success.
Inability of the surgeon to find the abnormal parathyroid gland-not missed multiglandular disease-is the main cause of operative failure in focused parathyroidectomy guided by IPM.
AuthorsJohn I Lew, Mariela Rivera, George L Irvin 3rd, Carmen C Solorzano
JournalArchives of surgery (Chicago, Ill. : 1960) (Arch Surg) Vol. 145 Issue 7 Pg. 628-33 (Jul 2010) ISSN: 1538-3644 [Electronic] United States
PMID20644124 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Parathyroid Hormone
  • Aged
  • Biomarkers, Tumor (blood)
  • Female
  • Humans
  • Hypercalcemia (blood, diagnosis)
  • Hyperparathyroidism, Primary (pathology, surgery)
  • Male
  • Middle Aged
  • Monitoring, Intraoperative (methods)
  • Parathyroid Hormone (blood)
  • Parathyroidectomy (methods)
  • Predictive Value of Tests
  • Prospective Studies
  • Retrospective Studies
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: